Profile data is unavailable for this security.
About the company
Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug development company with a focus on blood-related cancers. The Company’s highly productive drug discovery engine is driven by its expertise in amine oxidase inhibitors. Its lead candidate, PXS-5505, is used for the bone marrow cancer myelofibrosis, which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its PXS-4728 is a SSAO/MAOB inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis, and cardiac fibrosis. It has developed two respiratory products: Bronchitol, for cystic fibrosis, and Aridol, a lung function test.
- Revenue in AUD (TTM)9.83m
- Net income in AUD-14.26m
- Incorporated1998
- Employees107.00
- LocationSyntara Ltd20 Rodborough RdFRENCHS FOREST 2086AustraliaAUS
- Phone+61 29454-7200
- Fax+61 29451-3622
- Websitehttps://www.pharmaxis.com.au/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Auscann Group Holdings Ltd | 2.05m | -9.44m | 17.80m | 27.00 | -- | -- | -- | 8.69 | -0.0213 | -0.0217 | 0.0043 | 0.0162 | 0.1674 | -- | 5.35 | -- | -77.15 | -39.85 | -78.72 | -40.73 | 100.59 | -- | -460.74 | -925.91 | -- | -23.16 | 0.00 | -- | 13.88 | 51.37 | 57.10 | -- | -- | -- |
| Radiopharm Theranostics Ltd | 0.00 | -46.82m | 18.07m | -- | -- | 0.6134 | -- | -- | -0.1343 | -0.1343 | 0.00 | 0.0652 | 0.00 | -- | -- | -- | -63.11 | -- | -77.85 | -- | -- | -- | -- | -- | -- | -7.48 | 0.00 | -- | -- | -- | -13.78 | -- | -- | -- |
| Argent BioPharma Ltd | 1.32m | -17.02m | 18.34m | -- | -- | 10.90 | -- | 13.85 | -3.32 | -3.32 | 0.1003 | 0.0372 | 0.0813 | 0.7078 | 1.58 | -- | -105.32 | -111.29 | -345.98 | -171.05 | 21.87 | 32.52 | -1,295.20 | -632.42 | 0.6561 | -24.85 | 0.4104 | -- | -28.41 | 47.31 | -2.34 | -- | -16.20 | -- |
| Noxopharm Ltd | 3.90m | -12.13m | 18.41m | 1.00k | -- | 2.80 | -- | 4.72 | -0.0415 | -0.0415 | 0.0134 | 0.0225 | 0.2684 | -- | 1.64 | 3,901.84 | -83.43 | -50.96 | -94.78 | -62.98 | -- | -- | -310.82 | -191.70 | -- | -1.47 | 0.00 | -- | 11.32 | 44.02 | 19.34 | -- | -- | -- |
| Algorae Pharmaceuticals Ltd | 84.10k | -2.25m | 18.56m | -- | -- | 5.12 | -- | 220.70 | -0.0015 | -0.0015 | 0.00006 | 0.0022 | 0.0245 | -- | 1.79 | -- | -65.51 | -46.12 | -70.91 | -53.52 | -- | -- | -2,678.04 | -591.05 | -- | -136.75 | 0.00 | -- | 1,132.26 | -44.06 | -7.68 | -- | -- | -- |
| Acrux Ltd | 14.46m | -709.00k | 18.61m | 43.00 | -- | 3.29 | -- | 1.29 | -0.0024 | -0.0024 | 0.0502 | 0.0195 | 1.29 | -- | 4.86 | -- | -6.34 | -39.91 | -9.21 | -46.00 | 72.38 | -- | -4.90 | -132.53 | -- | -- | 0.2861 | -- | 133.74 | 28.29 | 92.23 | -- | -16.66 | -- |
| Rhythm Biosciences Ltd | 157.67k | -8.63m | 19.64m | -- | -- | 14.36 | -- | 124.56 | -0.0386 | -0.0386 | 0.0007 | 0.0055 | 0.0263 | -- | 1.81 | -- | -144.00 | -106.11 | -169.71 | -125.51 | -1,899.74 | -1,210.71 | -5,473.20 | -6,642.26 | 2.04 | -- | 0.0304 | -- | 814.18 | 28.77 | 6.55 | -- | -20.43 | -- |
| LTR Pharma Ltd | -100.00bn | -100.00bn | 19.71m | -- | -- | 6.21 | -- | -- | -- | -- | -- | 0.0451 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | -41.65 | -- | -- | -- |
| Immuron Ltd | 3.58m | -3.88m | 20.29m | 6.00 | -- | 1.16 | -- | 5.67 | -0.017 | -0.017 | 0.0157 | 0.0769 | 0.1664 | 0.6468 | 7.92 | 596,106.70 | -18.06 | -27.48 | -19.86 | -29.58 | 80.87 | 77.52 | -108.52 | -296.64 | 7.79 | -2.85 | 0.0023 | -- | 135.85 | -13.34 | -32.66 | -- | 3.27 | -- |
| Syntara Ltd | 9.83m | -14.26m | 21.49m | 107.00 | -- | 2.39 | -- | 2.19 | -0.0197 | -0.0172 | 0.0136 | 0.0075 | 0.442 | 1.58 | 2.22 | -- | -64.13 | -27.33 | -97.76 | -34.23 | 81.69 | 88.37 | -145.11 | -61.99 | 1.75 | -262.59 | 0.0674 | -- | 23.60 | -18.30 | -486.78 | -- | -31.06 | -- |
| Chimeric Therapeutics Ltd | 0.00 | -11.31m | 23.12m | -- | -- | 1.41 | -- | -- | -0.027 | -0.027 | 0.00 | 0.0191 | 0.00 | -- | -- | -- | -45.96 | -- | -69.36 | -- | -- | -- | -- | -- | -- | -10.01 | 0.1596 | -- | -- | -- | -60.40 | -- | -- | -- |
| BCAL Diagnostics Ltd | 3.67m | -5.00m | 23.72m | -- | -- | 3.90 | -- | 6.45 | -0.0227 | -0.0227 | 0.0166 | 0.0241 | 0.4493 | -- | 3.21 | -- | -61.10 | -54.01 | -67.83 | -62.57 | -- | -- | -136.00 | -248.64 | -- | -131.83 | 0.1985 | -- | 298.63 | 63.18 | -49.51 | -- | 91.62 | -- |
| Lumos Diagnostics Holdings Ltd | 12.41m | -13.33m | 24.07m | -- | -- | 1.73 | -- | 1.94 | -0.0358 | -0.0358 | 0.0352 | 0.029 | 0.3418 | 2.24 | 6.37 | -- | -36.70 | -40.15 | -55.14 | -56.67 | 59.73 | 45.97 | -107.38 | -162.90 | 0.479 | -6.25 | 0.4803 | -- | -9.42 | 39.29 | 80.38 | -- | -38.50 | -- |
| LBT Innovations Limited | 2.00m | -21.38m | 24.11m | 17.00 | -- | 8.88 | -- | 12.03 | -0.0428 | -0.0428 | 0.0038 | 0.002 | 0.1087 | 0.0819 | 2.25 | 117,882.40 | -115.89 | -28.85 | -131.86 | -30.99 | 94.76 | -- | -1,066.62 | -441.76 | 3.30 | -6.85 | 0.5633 | -- | -5.29 | -18.45 | -239.17 | -- | -34.63 | -- |
| Alterity Therapeutics Ltd | 123.46k | -12.28m | 26.23m | 11.00 | -- | 0.7951 | -- | 212.42 | -0.005 | -0.005 | 0.00005 | 0.0063 | 0.0044 | -- | 1.52 | 11,223.64 | -44.20 | -53.02 | -53.57 | -61.96 | -- | -- | -9,947.97 | -40,995.62 | -- | -- | 0.0143 | -- | 557.60 | -39.40 | -7.47 | -- | -34.88 | -- |
| BPH Energy Ltd | 345.67k | 894.65k | 26.34m | 2.00k | 24.49 | 1.18 | -- | 76.20 | 0.001 | 0.001 | 0.0004 | 0.0203 | 0.0177 | -- | 5.97 | -- | 4.58 | -6.89 | 4.78 | -7.72 | 56.39 | -- | 258.50 | -357.76 | -- | -- | 0.0043 | -- | 96.54 | 5.21 | 179.13 | -- | -- | -- |
Data as of May 13 2024. Currency figures normalised to Syntara Ltd's reporting currency: Australian Dollar AUD
